Ana I. Stancic
Plus aucun poste en cours
Profil
Ana I.
Stancic served as Chief Executive Officer, COO, CFO & Executive VP at Enzon Pharmaceuticals, Inc. from 2011 to 2012.
She was an Independent Director at AMAG Pharma USA, Inc. from 2012 to 2013, and at Genta, Inc. from 2011 to 2012.
She also served as an Independent Director at Champions Oncology, Inc. from 2011 to 2013.
Stancic was Vice President & Controller at Savient Pharmaceuticals, Inc. from 2003 to 2004, and Senior Vice President-Finance at ImClone LLC from 2004 to 2007.
She was Chief Accounting Officer & Vice President at Covanta Energy Corp.
from 1999 to 2002, and Chief Financial Officer at Omnicare LLC in 1999.
Stancic also served as Chief Financial Officer at Aureon Biosciences, Inc. from 2008 to 2009, and at OMRIX Biopharmaceuticals, Inc. from 2007 to 2008.
She was Chief Financial Officer & Senior Vice President at Aster Insights from 2010 to 2011.
Stancic earned an undergraduate degree from Montclair State University and an MBA from Columbia Business School.
Anciens postes connus de Ana I. Stancic
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/01/2015 |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Directeur/Membre du Conseil | 16/09/2013 |
| CHAMPIONS ONCOLOGY, INC. | Directeur/Membre du Conseil | 05/03/2013 |
| ENZON PHARMACEUTICALS, INC. | Directeur Général | 16/05/2012 |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Directeur/Membre du Conseil | 23/03/2012 |
Formation de Ana I. Stancic
| Montclair State University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CHAMPIONS ONCOLOGY, INC. | Health Technology |
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Covanta Energy Corp.
 Covanta Energy Corp. Alternative Power GenerationUtilities Covanta Energy Corp. operates waste-to-energy generation facilities. The company was founded in 1986 and is headquartered in Fairfield, NJ. | Utilities |
Omnicare LLC
 Omnicare LLC Drugstore ChainsRetail Trade Omnicare LLC provides pharmaceutical services to patients and providers. It serves long term and post acute facility services and senior living. The company was founded on May 19, 1981 and is headquartered in Cincinnati, OH. | Retail Trade |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
Aster Insights
 Aster Insights BiotechnologyHealth Technology M2Gen Corp. provides informatics-based solutions to accelerate the discovery, development, and delivery of personalized medicine. Its solutions include Total Cancer Care Protocol and ORIEN Avatar. The company was founded by William S. Dalton in 2006 and is headquartered in Tampa, FL. | Health Technology |
Aureon Biosciences, Inc.
 Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Health Technology |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Health Technology |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |